Therefore, various genetic tools for treating LRRK2 G2019S mutations, such as ZFN, HDAdV, BAC-based HR, CRISPR/Cas9, and ABE, could suggest therapeutic strategies for other genetic diseases as well. The gene discussed is LRRK2; the disease is hereditary disease.